Back to news

Why Humana Stock Is Falling Today

Investivoq PriceTracker

Humana (HUM) is down 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: A single fresh company-specific negative catalyst is not obvious, so the move appears tied more to positioning around Medicare Advantage Star Ratings and a pullback after a recent analyst-driven rally. This could be because investors are reassessing expectations ahead of a key CMS update that can affect future reimbursement and bonus economics.

Details:

  • Humana did not appear to post a major new earnings release or material SEC filing today, which makes a clear same-day operational shock harder to identify.
  • CMS has indicated that 2027 Medicare Advantage Star Ratings are due on or around October 8, and those ratings are important because they influence future quality bonus payments and plan economics.
  • Humana had recently benefited from bullish analyst calls tied to expectations for better Medicare margins and improved Star Ratings, so part of today’s decline may reflect profit-taking or reduced confidence ahead of that catalyst.
  • Humana’s October 1 update on 2027 Medicare Advantage offerings emphasized broad geographic reach, low-premium options, and $0 in-network primary care and routine lab benefits, which does not point to an obvious negative product announcement as the trigger.

    • Sources:

    Humana, SEC, CMS, TipRanks

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    EARLY ACCESS
    Receive HUM Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $HUM Hedge Fund Activity

    We have seen 522 institutional investors add shares of $HUM stock to their portfolio, and 354 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • JPMORGAN CHASE & CO added 3,234,637 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,284,862,509
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,370,831 shares (+inf%) to their portfolio in Q2 2026, for an estimated $544,521,489
    • PZENA INVESTMENT MANAGEMENT LLC removed 1,067,846 shares (-19.5%) from their portfolio in Q2 2026, for an estimated $424,169,788
    • CAPITAL WORLD INVESTORS added 927,924 shares (+981.9%) to their portfolio in Q2 2026, for an estimated $368,589,971
    • INVESCO LTD. removed 907,025 shares (-38.0%) from their portfolio in Q2 2026, for an estimated $360,288,470
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 904,125 shares (-20.2%) from their portfolio in Q2 2026, for an estimated $359,136,532
    • EAGLE CAPITAL MANAGEMENT LLC added 879,688 shares (+29.6%) to their portfolio in Q2 2026, for an estimated $349,429,667

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $HUM Analyst Ratings

    Wall Street analysts have issued reports on $HUM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Guggenheim issued a "Buy" rating on 04/30/2026

    To track analyst ratings and price targets for $HUM, check out Investivoq's $HUM forecast page.

    $HUM Price Targets

    Multiple analysts have issued price targets for $HUM recently. We have seen 14 analysts offer price targets for $HUM in the last 6 months, with a median target of $320.0.

    Here are some recent targets:

    • Ben Hendrix from RBC Capital set a target price of $415.0 on 07/09/2026
    • Sarah James from Cantor Fitzgerald set a target price of $300.0 on 07/07/2026
    • Kevin Fischbeck from B of A Securities set a target price of $380.0 on 06/24/2026
    • Elizabeth Suzuki from Evercore ISI Group set a target price of $370.0 on 06/11/2026
    • Lisa Gill from JP Morgan set a target price of $316.0 on 06/08/2026
    • Ann Hynes from Mizuho set a target price of $390.0 on 06/08/2026
    • Erin Wright from Morgan Stanley set a target price of $249.0 on 06/04/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.